ITMCTR2000003400招募中1 期
Clinical efficacy evaluation of Qingda Granule in the treatment of hypertension (grade 1, low to medium-risk) patients: a multicenter, randomized, double-blind, double-simulated, parallel-controlled, non-inferiority clinical study
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 20 至 75（—）
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria for essential hypertension measured in the same clinic, the hypertension is graded as grade 1, and the risk stratification is low to medium risk (refer to the 2018 Revision of Chinese Guidelines for The Prevention and Treatment of Hypertension);
- •2. Did not take or did not take blood pressure medicine regularly within one month;
- •3. Between 20 and 75 years old (including boundary value);
- •4. Agree to sign the informed consent.
排除标准
- •1. Patients with obvious liver and kidney diseases or with ALT and AST 1.5 times higher than ULN, Cr and BUN higher than ULN;
- •2. Patients with serious mental illness, hematopoietic disease, malignant tumor and other major diseases;
- •3. Women who are pregnant or preparing for pregnancy, and women who are breastfeeding;
- •4. Have participated in or are participating in other clinical researchers in the past three months;
- •5. Suspected or definite allergy to the study drug.
研究者
相似试验
尚未招募
1 期
Clinical evaluation of Kang's Ling-He Granules in the treatment of obese metabolic-related fatty liver diseaseMetabolically associated fatty liver diseaseITMCTR2200006024Xiamen Hospital of TCM
招募中
不适用
Evaluation of the clinical efficacy of Qinghuatanshi Decoction in the treatment of Plasma cell mastitis during perioperative periodPlasma cell mastitisITMCTR2100005055Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
招募中
不适用
The clinical research for Jiedu Qingnao granules additional treatment on first episode schizophreniaSchizophreniaITMCTR1900002841Beijing Anding Hospital, Capital Medical University
已完成
不适用
Investigation of clinical efficacy of Qing-Dai for patients with crohn's disease who have the loss of responsiveness for anti-TNF agentss diseaseCrohn's diseaseJPRN-UMIN000019249Division of Gastroenterology and Hepatology, School of Medicine, Keio University10
尚未招募
4 期
Evaluation of the clinical efficacy of Guanxinning tablets in the treatment of patients with carotid atherosclerotic plaqueCarotid atherosclerotic plaque formationITMCTR2100005440Dongzhimen Hospital, Beijing University of Chinese Medicine